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Abstract 
Purpose: To report a case in which an early, massive silicone oil migration into the subcon-
junctival space occurred in a patient after sutureless vitrectomy with the presence of a previ-
ously implanted pars plana glaucoma drainage device. Case Report: An 80-year-old man pre-
sented with neovascular glaucoma secondary to a proliferative diabetic retinopathy in his left 
eye. After an intracamerular bevacizumab injection and panretinal photocoagulation, a 23-
gauge pars plana vitrectomy (PPV) combined with a superotemporal Ahmed pars plana glau-
coma valve implantation was performed. Afterwards, the patient underwent a new 23-gauge 
PPV for a dense vitreous hemorrhage. Intravitreal 1,000 centistokes silicone oil was placed to 
prevent recurrent intraocular bleeding. No sutures were performed. In the first postoperative 
month, a massive migration of silicone oil into the 360° subconjunctival space was noted until 
no intraocular silicone oil was observed. Conclusions: We discuss the possible leakage mech-
anisms in this particular case. © 2018 The Author(s) 
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Neovascular glaucoma (NVG) is an end-stage complication of ischemic retinal vascular 
diseases like proliferative diabetic retinopathy or central retinal vein occlusion. Silicone oil 
(SO) has been used as an adjunct for internal tamponade in vitreoretinal surgery in these pa-
tients. On the other hand, it is often necessary to implant glaucoma drainage devices (GDDs) 
for the management of refractory NVG. Then, it is not uncommon to associate pars plana 
vitrectomy (PPV) with SO injection and glaucoma drainage implants.  
We report a rare case in which an early, massive SO migration into the subconjunctival 
space occurred in a patient after sutureless PPV with the presence of a previously implanted 
pars plana GDD. We discuss the possible leakage mechanisms. 
Case Report 
An 80-year-old man without any known past medical history presented with NVG sec-
ondary to a proliferative diabetic retinopathy in his left pseudophakic eye. The patient re-
ceived an intracamerular bevacizumab injection and panretinal photocoagulation. After-
wards, the patient underwent a 23-gauge PPV combined with a superotemporal Ahmed pars 
plana glaucoma valve implantation. A scleral patch with a fornix-based conjunctival flap was 
made and the tube was located in the vitreous cavity with complete success in intraocular 
pressure (IOP) control. Fifteen months after surgery, the patient underwent a new 23-gauge 
PPV for a dense vitreous hemorrhage. Intravitreal 1,000 centistokes (cs) SO was placed to 
prevent recurrent intraocular bleeding. No sutures were performed. During the first postop-
erative month, a progressive migration of SO into the 360° subconjunctival space was noted 
until no intraocular SO was observed (Fig. 1). The patient had no symptoms and best-cor-
rected visual acuity remained at no light perception in his left eye. Magnetic nuclear resonance 
was performed in order to rule out the presence of SO in the orbit. One month after surgery, 
SO was then incompletely removed from the subconjunctival space although attempts were 
made to withdraw all subconjunctival SO (Fig. 2). Sclerotomies were intraoperatively revised 
and no leakage was observed. 
Discussion 
Intraocular SO migration into the subconjunctival space through a glaucoma tube shunt 
or through unsutured sclerotomies has been previously reported [1–7]. In this particular case, 
a sutureless PPV and a pars plana tube GDD coexist, so the question is: Where did the subcon-
junctival SO come from? 
It is interesting that massive extravasation of SO already occurred during the first month 
after its placement in the absence of oil emulsification. It is also remarkable that SO filled the 
360° subconjunctival space from the beginning of the migration and was not limited to the 
bleb or around the valve body. Slow emulsified SO migration through a GDD mature capsule 
and conjunctival tissue infiltration with SO has been described in the past for nonrestrictive 
devices [1, 2]. A rare case of early and massive subconjunctival and orbital migration through 
an Ahmed glaucoma valve implant has also been reported when SO comes into contact with 
the tube and the capsule has not yet formed [3]. In our patient, the capsule was already formed 
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and leakage could be explained by the presence of a pore in the mentioned capsule or a too 
broad scleral tunnel that allowed the oil to escape. 
Replacing the tube in the posterior chamber to prevent contact with SO would have prob-
ably been the preferred option. Nevertheless, since the visual acuity of the patient was no light 
perception, we opted for conservative management in order to avoid greater manipulation. 
The 23-gauge transconjunctival sutureless vitrectomy with SO injection is commonly ac-
cepted by vitreoretinal surgeons since its introduction in 2005 [8]. No massive SO migration 
has been reported up to date, although limited subconjunctival SO leakage occurs frequently 
after vitrectomy. Some reports describe tiny subconjunctival SO bubbles with an incidence of 
8–10%, sometimes with mild postoperative discomfort [4]. 
Silicone bubbles are usually difficult to detect at the slit lamp exam. Histopathological 
studies have demonstrated that small drops of silicone are found in 30% of eyes after suture-
less PPV [5]. Our observations using Visante OCT after PPVs with SO injection confirm this 
frequency (data not published). 
Viscosity of the SO may influence its leakage through the sclerotomy. With the advent of 
microincision PPV, surgeons usually prefer less viscous SO which can be introduced and re-
moved more easily through the small cannulae. But the lower the viscosity, the lower the sur-
face tension, so less viscous SO can easier pass through an unsutured sclerotomy than more 
viscous SO. 
Reported cases of subconjunctival SO migration describe the use of 1,000 cs or viscosity 
is not specified. Probably the use of higher viscous SO may prevent its leakage. 
The diameter of the hole through which SO has to pass is another important aspect to take 
into account. The microcannula has an internal diameter of 0.65 mm and an external diameter 
of 0.75 mm. On the other hand, the tube of the Ahmed valve has an internal diameter of 0.3 
mm and an external diameter of 0.63 mm. GDDs have narrower diameters compared with 
cannulae in microincision PPV. Then, SO may migrate easier through sclerotomies than 
through the tube of the GDD in case both of them were open. 
A main concern about SO leakage is the wound sealing. Some advices have been recom-
mended in order to achieve a tight self-sealing wound at the end of the surgery: make the 
incision at about 30º through the eye wall, minimizing the stretching of the sclera during sur-
gical maneuvers, having a normal IOP before removing the microcannulae or use bipolar cau-
tery in the conjunctiva over the wound [6]. Anyway, the safest maneuver is suture all sclerot-
omies when SO is used in order to avoid its leakage. Sometimes a loop suture is left in place 
and can be removed a few days after in the office. 
Measures to control SO migration leakage, like tube removal or ligature, could be consid-
ered with high risk of IOP control loss. Modifying the tube placement in the inferotemporal 
quadrant of the anterior chamber can also be considered as an option but, as SO often takes 
many months to migrate, it is not usually performed in order to minimize manipulation. 
Attempts to totally remove subconjunctival SO have limited success as infinite oil micro-
drops infiltrate subconjunctival tissues and fibrous septa usually appears. 
In conclusion, the amount of SO migration, timing from surgery, and 360° subconjunctival 
location suggest that an unsutured sclerotomy or a large defect in the capsule of the GGD may 
be the source of leakage in our patient. A lower threshold to check over GDD implants and 
suture sclerotomies in silicone cases is recommended. 
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Fig. 1. Conjunctival appearance 3 weeks after pars plana vitrectomy and silicone oil injection. A big silicone 




Fig. 2. Conjunctival appearance 2 months after pars plana vitrectomy and silicone oil injection. Countless 
silicone oil microbubbles fill the subconjunctival space in the superotemporal quadrant. 
 
